Pubblicazioni

Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors

2024 - EXPERT OPINION ON PHARMACOTHERAPY

Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo

Advances in drug treatments for mesothelioma

2022 - EXPERT OPINION ON PHARMACOTHERAPY

Zucali, Paolo Andrea; De Vincenzo, Fabio; Perrino, Matteo; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Fazio, Roberta; Pirozzi, Angelo; Santoro, Armando

Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy

2019 - EXPERT OPINION ON PHARMACOTHERAPY

Morano, A.; Iannone, L.; Palleria, C.; Fanella, M.; Giallonardo, A. T.; De Sarro, G.; Russo, E.; Di Bonaventura, C.